Literature DB >> 31740110

Mental health diagnoses and early removal of long-acting reversible contraception.

Jennifer K Bello1, Joanne Salas2, Dixie Meyer2, Katie Heiden-Rootes2, Dawn M Davis2, Elizabeth Keegan Garrett2, Mattie M White3, Preethi Schmeidler4.   

Abstract

BACKGROUND: Having a mental health diagnosis is associated with contraceptive non-adherence and user-related contraceptive failures of short-acting methods. There is a lack of research on the relationship between mental health diagnoses and early discontinuation of highly effective long-acting reversible (LARC) methods such as the intrauterine device (IUD) and subdermal implant (SDI).
METHODS: Using a Primary Care and Obstetrics and Gynecology Patient Data Registry, we conducted a cross-sectional analysis of the relationship between any mental health diagnosis (any anxiety disorder or depression) and early LARC removal (<1 year post-insertion) among 385 reproductive-aged (14-50 years) women in 2008-16. Adjusted logistic regression was used to calculate odds ratios and 95% confidence intervals.
RESULTS: Almost 10% (n = 37) of the sample had an early LARC removal, of which 62.2% were hormonal IUD and 37.8% were SDI. Women with a mental health diagnosis had a higher prevalence of early LARC removal (13.6% vs. 8.0%, p = =.090). Although non-significant, there was a trend in adjusted analyses indicating twice the odds of early removal for women with a mental health diagnosis versus no diagnosis (OR = =2.04, 95% CI = =0.97-4.27). LIMITATIONS: This study is limited by a small sample size and availability of variables from a reportable medical record database. Pregnancy intentions and side effects of method use could not be accounted for which may have impacted timing of removal.
CONCLUSIONS: Understanding why women choose early LARC removal can inform counseling to help women make informed choices about their contraceptive method that meets their reproductive needs.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Anxiety; Contraception; Depression; Long-Acting Reversible Contraception (LARC)

Mesh:

Year:  2019        PMID: 31740110     DOI: 10.1016/j.jad.2019.11.046

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  2 in total

1.  The association between depression and contraceptive behaviors in a diverse sample of new prescription contraception users.

Authors:  Deborah Quint Shelef; Tina Raine-Bennett; Malini Chandra; Nancy Adler; Cassondra J Marshall; Julia R Steinberg
Journal:  Contraception       Date:  2021-09-02       Impact factor: 3.375

2.  Associations between use of psychotropic medications and use of hormonal contraception among girls and women aged 15-49 years in Finland: a nationwide, register-based, matched case-control study.

Authors:  Elena Toffol; Timo Partonen; Oskari Heikinheimo; Anna But; Antti Latvala; Jari Haukka
Journal:  BMJ Open       Date:  2022-02-22       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.